一项观察性研究,以确定MP-AzeFlu®在奥地利持久性过敏性鼻炎患者的现实生活中的有效性
Katharina Marth1, Andreas Renner2, Georg Langmayr3
1Department of Pulmonology, Karl Landsteiner Institute for Experimental and Clinical Pneumology, Hietzing Hospital, 1130, Vienna, Austria. katharina.marth@gesundheitsverbund.at.
Drugs - real world outcomes
|February 14, 2024
概括
医药公司 Meda 医药公司 Meda Pharma
科学领域:
- 过敏和免疫学 过敏和免疫学
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 中度至严重的持续性过敏性鼻炎 (AR) 影响了许多患者.
- 梅达制药公司的AzeFlu (MP-AzeFlu) 是一种新的鼻内治疗方法,结合了azelastine化和fluticasone propionate.
- 这种组合治疗是通过单一,方便的设备进行的.
研究的目的:
- 评估MP-AzeFlu在控制奥地利持久性过敏性鼻炎方面的实际有效性.
- 评估MP-AzeFlu在减少AR症状方面的速度和有效性.
- 了解患者的人口统计和持久性AR的先前治疗模式.
主要方法:
- 一项前性观察性研究,涉及奥地利214名中度至重度持久性AR的成人和青少年.
- MP-AzeFlu是每天两次以每鼻孔的喷雾剂进行的.
- 使用视觉模拟尺度 (VAS) 测量了有效性,用于在42天内测量症状严重程度.
主要成果:
- 与基线相比,MP-AzeFlu显示了VAS得分的快速和统计显著下降.
- 平均VAS得分从基线时的53.5mm下降到42日的19.6mm.
- 治疗有效性在不同患者人口统计和AR表型中是一致的.
结论:
- MP-AzeFlu在现实世界的奥地利临床环境中提供了对持续性过敏性鼻炎的有效和快速控制.
- 这些发现表明MP-AzeFlu是患有不受控制的持续性AR的患者的有价值的治疗选择.
- 该研究强调了在奥地利需要有效治疗持续性AR的需要.
更多相关视频
03:40Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
Published on: December 20, 2024
480
11:54Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples
Published on: January 21, 2018
30.3K
相关概念视频
01:17Drugs Used in Lower Respiratory Disorders: Overview
442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442
01:30Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K